SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-059778
Filing Date
2023-11-07
Accepted
2023-11-07 08:00:48
Documents
52
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q maia-20230930.htm   iXBRL 10-Q 1863695
2 EX-31.1 maia-ex31_1.htm EX-31.1 18688
3 EX-31.2 maia-ex31_2.htm EX-31.2 19069
4 EX-32.1 maia-ex32_1.htm EX-32.1 11159
5 EX-32.2 maia-ex32_2.htm EX-32.2 12424
  Complete submission text file 0000950170-23-059778.txt   6525887

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT maia-20230930_cal.xml EX-101.CAL 29970
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT maia-20230930.xsd EX-101.SCH 46703
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT maia-20230930_lab.xml EX-101.LAB 382517
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT maia-20230930_def.xml EX-101.DEF 142829
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT maia-20230930_pre.xml EX-101.PRE 269498
46 EXTRACTED XBRL INSTANCE DOCUMENT maia-20230930_htm.xml XML 951629
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41455 | Film No.: 231381642
SIC: 2834 Pharmaceutical Preparations